2019

Hooda N, Quinn E, DeAngelis C, Pasetka M, McFarlane T. 2019. Delayed CINV in FOLFOX chemotherapy: A retrospective chart review comparing two Ontario hospitals. Poster presented at the Canadian Association for Pharmacy in Oncology Annual Conference, Halifax, NS, April 2019.

Babik I, Movva N, Cunha A, Lobo MA. 2019. Characterization of self-feeding and problem solving in children with arm movement impairments. Poster presented at the Society for Research in Child Development Biennial Conference, Baltimore, MD. March 2019.

Mavunda K, Jiang X, Ambrose C. The prevalence of diagnosed chronic lung disease in US infants by gestational age: Implications for RSV policy. Celebration of Pediatric Pulmonology and Sleep, Orlando, FL, February 2019.

Frankenfeld CL, Leslie TF, Menon N. Racial disparities in colorectal cancer time-to-treatment in relation to residential segregation of the diagnostic hospital. Poster presentation to American Public Health Association, 2019.

2018

Frankenfeld CL. Residential segregation and health disparities. George Mason University Health Administration Policy/Center for Health Policy, Research, and Ethics Seminar, November 28, 2018.

Fryzek JP, Bylsma LC, Nordyke RJ, Sorensen HT. Rare disease epidemiology: A Danish population-based program. Poster presented at National Organization for Rare Disorders’ Rare Disease and Orphan Products Breakthrough Summit, Washington, DC, October 2018.

Jensen IS, Wu E, Sacks NC, Cyr PL, Chung KC. 2018. Budget impact analysis of using daunarubicin-cytarabine liposome in patients with newly diagnosed therapy-related AML or AML and myelodysplasia-related changes. Am Health Drug Benefits 11(7):380–386. PMID: 30647825.

View Abstract

Frankenfeld CL. Intersection of epidemiology and geography: Residential segregation and health disparities. George Mason University Geography and Geoinformation Science Colloquium, October 10, 2018.

Ambrose C, Jiang X, Mavunda K. The prevalence of diagnosed chronic lung disease in US infants by gestational age: Implications for RSV policy. ID Week, San Francisco, CA, October 4, 2018.

Sacks NC, Sharma A, Cyr PL, Bertiger G, Dahdal DN, Brogadir S. 2018. Real-world comparison of the effectiveness and safety of different bowel preparation agents. Clin Exp Gastroenterol 11(Aug 16):289–299; doi: 10.2147/CEG.S171861. PMID: 30555250.

View Abstract